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Background. Severe malaria is prevalent globally, yet it is an uncommon disease posing a challenge to education in nonendemic
countries. High-ﬁdelity simulation (sim) may be well suited to teaching its management. Objective.T od e v e l o pa n de v a l u a t ea
teaching tool for severe malaria, using sim. Methods. A severe malaria sim scenario was developed based on 5 learning objectives.
Sim sessions, conducted at an academic center, utilized METI ECS mannequin. After sim, participants received standardized
debrieﬁngandcompletedatestassessinglearningandasurveyassessingviewsonsimeﬃcacy.Results.29participantsincluded3rd
year medical students (65%), 3rd year EM residents (28%), and EM nurses (7%). Participants scored average 85% on questions
related to learning objectives. 93% felt that sim was eﬀective or very eﬀective in teaching severe malaria, and 83% rated it most
eﬀective. All respondents felt that sim increased their knowledge on malaria. Conclusion. Sim is an eﬀective tool for teaching severe
malaria in and may be superior to other modalities.
1.Introduction
Malaria accounts for over 1 million deaths per year. The
greatest burden of malaria morbidity and mortality occurs
in children under 5 years of age in Africa [1]. Travel and
migration increasingly transport malaria to the USA and
other industrialized countries, up to 30,000 cases per year by
some estimates [2]. In 2005, surveillance from the Centers
for Disease Control identiﬁed 1528 cases of malaria in the
USA, a 15% increase from the previous year and the greatest
number since 1980 [3]. Plasmodium falciparum, the species
responsibleforseveremalaria,accountedfor48%ofthecases
and caused all 7 fatalities [3]. Severe malaria refers to malaria
with signs of end organ dysfunction, as manifested by coma,
pulmonary edema, renal failure, circulatory collapse, or
severe anemia [4]. In general, 5% of imported cases progress
to severe malaria, which in turn carries 20% mortality [2].
In non-endemic countries, malaria poses a signiﬁcant
challenge to medical education. Despite its worldwide
importance,malariaisuncommonlyencounteredbymedical
trainees and physicians in practice. It is a complex and lethal
condition with the potential for rapid deterioration from
nonspeciﬁc fever to multiorgan failure. Managing malaria
thus requires time-critical actions, often on the basis of a
presumptivediagnosis[4].Unfortunately,delaysindiagnosis
are common [3, 5]. One can also suspect that discontin-
uation of quinidine as an emergency antiarrhythmic drug
further reduces prescribing experience with the only widely
available treatment for severe malaria in the USA. Lack of
physician familiarity with the diagnosis and treatment of
malaria contributes heavily to preventable malaria deaths in
non-endemic countries [3, 5–7].
This paper proposes that the challenge of teaching severe
malaria in non-endemic areas is particularly amenable to the
use of high-ﬁdelity simulation. The objective was to develop
a novel teaching tool for severe malaria, using high-ﬁdelity
simulation that emphasizes predeﬁned learning objectives
for the disease. High-ﬁdelity simulation refers to simulation
scenarios with mannequins that can reproduce a wide range
of patient characteristics. According to a recent review of
simulation in emergency medicine [8], the “high ﬁdelity”
dependson(1)therealismofthemannequinanditssoftware
(i.e., the simulator), (2) the realism of the environment, and
(3) a psychological realism as perceived by the participant.2 Journal of Tropical Medicine
2. Methods
ThesimulationcenterisequippedwiththeMETIEmergency
Care Simulator (METI ECS), a high-ﬁdelity patient simula-
tor that blinks, breathes, has palpable pulses, and speaks thr-
ough a speaker linked to an instructor in the control room.
(Additional information is available from Medical Education
Technologies, Inc, Sarasota, Fl, http://www.meti.com/.) The
METI ECS is located in a simulated emergency department
resuscitation room complete with monitors, a code cart, and
standard intravenous equipment and medications. The soft-
ware of METI ECS permits the creation of multiple physio-
logic states, which can be programmed to worsen with time
and to respond to therapeutic maneuvers. Certain physical
ﬁndings that are not easily simulated on a mannequin, such
as dry mucous membranes, can be communicated as obser-
vationsfromthepatient’snurse,whoisoneofthesimulation
instructors. The simulation is directed by a lead instructor
in the control room and facilitated by an in-scenario, role-
playing nurse.
The authors observed several simulation scenarios in
progress to learn the capabilities of the simulation center and
to adapt a malaria case scenario to the simulation enviro-
nment. Learning objectives were derived from a selection of
recent publications searched for in MEDLINE under malaria
and severe malaria, with limits “review”, and from their
respective reference lists [2, 4, 9–15], as well as from the au-
thors’ prior experience in teaching malaria. Special emphasis
was placed on developing learning objectives that would
address typical pitfalls in the diagnosis and management of
malaria in non-endemic countries. A simulation scenario
was designed and pilot-tested to address the learning objec-
tives below.
3.LearningObjectivesfor SevereMalaria
The summarized learning objectives were as follows (see the
online emergency medicine simulation scenario library for
full learning objectives at http://www.emedu.org/simlibrary
or at http://www.aamc.org/mededportal [16]).
Objective 1: Recognize High-Risk Groups for Malaria. Any
traveler to an endemic area in the year prior to presentation
should be considered at risk for the disease [6]. Immigrants
originally from endemic countries are at particularly high
risk, because they are much less likely to take malaria
prophylaxis when they travel to visit family abroad [17]. The
travel history is crucial to identify the susceptible patient, as
any travel to the tropics constitutes a risk.
Objective 2: Establish a Deﬁnitive or Presumptive Diagnosis
of Malaria. Fever is the most common initial manifestation
of malaria, accompanied variably by headache, myalgias,
jaundice, vomiting, abdominal pain, cough, and diarrhea
[4]. The non-speciﬁc nature of symptoms in early, uncom-
plicated malaria necessitates a focused diﬀerential diagnosis
that includes other life-threatening infectious diseases that
beneﬁt from prompt antibiotic treatment. Thick and thin
blood smears are the backbone of laboratory diagnosis.
Blood smears, however, are not always immediately read by
trained personnel, and false-negatives occur. A presumptive
diagnosis of malaria is warranted in any seriously ill patient
who is at risk for malaria and treatment should never be
delayed in the wait for a positive blood smear [4]. This
frequent reliance on a presumptive scenario further high-
lights the importance of obtaining recent travel history on
all patients presenting with fevers: unless health care workers
habitually ask febrile patients about travel to the tropics, they
will miss an opportunity to diagnose and treat malaria and
other life-threatening tropical diseases. Additionally, some
institutions may have Rapid Diagnostic Tests (RDTs) for
diagnosing malaria. A Rapid Diagnostic Test (RDT) is an
alternate way of quickly establishing the diagnosis of malaria
infection by detecting speciﬁc P. falciparum antigens in a
person’s blood. RDTs have recently become available in the
United States. These RDTs, whether negative or positive,
must always be followed up by microscopy, as they will
miss nonfalciparum malaria, and cannot measure levels of
parasetemia.
Objective 3: Identify and Treat the Complications of Severe
Malaria. Antimalarial therapy should be initiated on the
basis of a presumptive diagnosis in any seriously ill patient
whoisatriskformalaria[4].Comaandacidosisarethemost
common manifestations of severe malaria in adults. Renal
failure, seizures, hypoglycemia, severe malaria, disseminated
intravascular coagulation (DIC), and noncardiogenic pul-
monary edema (ARDS) are other important complications
of severe malaria. The most important step in managing the
complications of severe malaria is the prompt initiation of
antimalarial drugs [4]. All complications of malaria should
be treated as they would for any critically ill patient, with
the caveat that malaria patients are more prone to ﬂuid
overload than septic patients and thus require cautious ﬂuid
administration [12, 13].
Objective 4: Know the Treatment for Severe Malaria and
Its Complications. Intravenous artesunate is now the World
Health Organization- (WHO-) recommended ﬁrst-line
treatment for severe malaria [18]. Artesunate has proved
itself superior to intravenous quinine in both adults and
children, dropping treatment with quinine to second line
[18–20]. Artesunate and other related compounds have
av e r yg o o ds a f e t yp r o ﬁ l ew i t hf e wa d v e r s ee ﬀects: mild
gastrointestinal symptoms may occur, while hypersensitivity
reactions are on the order of 1 in 3000 [18]. Artesunate
was approved as a new investigational drug in the United
States on June 21st, 2007 (IND protocol no. 76,725, entitled
Intravenous Artesunate for Treatment of Severe Malaria in
the United States) and makes a new class of antimalarial
medication, artemisinins, available in the United States [21].
High-quality intravenous artesunate is available only to
malaria patients hospitalized in the United States who need
intravenous treatment because of severe malaria disease,
high levels of malaria parasites in the blood, inability to
take oral medications, lack of timely access to intravenous
quinidine, quinidine intolerance or contraindications, or
quinidine failure. The drug can be provided to hospitalsJournal of Tropical Medicine 3
upon request and on an emergency basis by the CDC (see
contact details below) through the DCD Drug Service or
by one of the CDC Quarantine Stations located around the
United States. In the USA, artesunate is currently stocked in
airports in 9 major cities. Clinicians located in these major
cities might therefore receive artesunate within minutes of
calling the CDC, though delivery may take several hours in
othercitiesorinotherlocations.TheCDCreportsanaverage
call to infusion time of 7 hours (personal communication
February 2011).
Because parenteral forms of artesunate and quinine are
not always immediately available in the United States and
other non-endemic countries and because timely initiation
of an eﬀective anti-malarial is crucial, quinidine gluconate
may still occasionally be the drug of choice. Quinidine is a
more eﬀective anti-malarial than quinine but is more car-
diotoxic and thus requires continuous electrocardiographic
monitoring [6]. Since quinidine too has been in short supply
in the USA [21], one might consider initiating a drug with
anti-malarial activity (such as intravenous clindamycin or
doxycycline) while awaiting delivery of artesunate. In cases
of severe malaria with elevated parasitemia (>10% of red
blood cells on a thin smear) that do not respond promptly
to antimalarials, one may consider an exchange transfusion,
although there is no strong clinical evidence to support its
use [6, 15].
Objective 5: Identify Resources for Assistance in the Manage-
ment of Malaria. Emergency medicine physicians and other
critical care providers should know what resources are rapi-
dly available to assist in the management of malaria. The we-
bsiteoftheCentersforDiseaseControl(CDC)athttp://www
.cdc.gov/malaria is a resource, and a CDC malaria specialist
is also available 24 hours a day for telephone consultations
(770-488-7788 daytime, and 770-488-7100 after working
hours and weekends) [5] .T h es a m eC D Cm a l a r i as p e c i a -
list can authorize and organize an emergency delivery of
artesunate (http://www.cdc.gov/malaria/diagnosis treatme-
nt/artesunate.html)[ 21]. Although a consult to an infectious
disease expert as well as an inpatient pharmacist for dosing
assistance can be of use, the CDC has the expertise and the
means to provide up-to-date and rapid advice in treating
these patients and is highly recommended by these authors.
4. SimulationScenarioandEvaluation
After the initial pilot test, the scenario was conducted 5 times
between March 13 and September 4, 2008 in the simulation
center described above. The simulations were run during
weekly “simulation days” for medical students, nurses, and
emergency medicine residents working in the emergency
department. Some participants were directly involved in the
simulated patient care, while others watched from a video-
linked conference room.
The scenario involves a 34-year-old female who compl-
ains of fever, vomiting, headache, and malaise within a week
after visiting family in Nigeria. (For the full scenario, along
with simulation case manager instructions, see the online
Table 1: Demographics.
N = 29
Level of participation Observer Participant
13 (45%) 16 (55%)
Level of training MS3 EM PGY3 RN
19 (65%) 8 (28%) 2 (7%)
Specialty EM None listed
9 (31%) 20 (69%)
simulation scenario library at http://www.emedu.org/sim-
library or http://www.aamc.org/mededportal). She did not
take malaria prophylaxis but took all of her son’s left-over
erythromycin after becoming ill. She initially presents with a
normal mental status but is febrile, tachycardic, tachypneic,
and ill appearing. She soon seizes and becomes obtunded.
Laboratory tests reveal a signiﬁcant anion-gap acidosis, but
the blood smear is not immediately available. An EKG will
show sinus tachycardia with QT prolongation. If participants
recognizeseveremalariaandtreatwithquinidine,thepatient
will develop torsades de pointes. In order to prevent a
premature end to the scenario, the role-playing nurse who
is part of the simulation center staﬀ will cue participants as
necessary to take actions that will keep the scenario moving
and the patient alive.
The objective-related critical actions are as follows: to
recognize that the patient is at high risk (Objective 1) and
to order the appropriate tests for malaria and other diseases
in the diﬀerential diagnosis (Objective 2); to identify seizure,
coma, and acidosis as manifestations of severe malaria,
and also to remember to look for or treat hypoglycemia
(Objective 3); to provide supportive care, including ﬂuid
resuscitation, anticonvulsants, and endotracheal intubation
as necessary (Objective 3); to start empiric therapy for
severe malaria with intravenous artesunate if available (by
calling the CDC if in the USA), quinidine, quinine, or a
temporizing alternative; to recognize the complications of
treatment(Objective4);toseekoutsidehelpformalariacare,
including specialist consultation. (Objective 5).
After the scenario, participants received a standardized
debrieﬁng on the case, including discussion of the 5 learning
objectives for severe malaria and their associated critical
actions. Participants then took a 20-question survey, which
included 8 multiple choice test questions relevant to the 5
learning objectives.
5. Results
29 learners, 16 participants, and 13 observers were included
in 5 simulation sessions. Trainees included 19 3rd year
medical students, 8 3rd year EM residents, and 2 nurses
(Table 1). There was no relationship between learner group
(observer or participant) and trainee position (P = .33).
Among all learners (observers and participants), simulation
was rated a “very eﬀective” instructional method by 66%
(95% CI 48, 83), equivalent to actual patient care by 67%4 Journal of Tropical Medicine
Table 2: Prior malaria teaching, prior simulation experience, and teaching eﬀectiveness.
N = 29 Yes No
Any prior malaria
teaching
27 (93%) 2( 7 % )
Exposure to malaria
teaching methods and
rated eﬀectiveness
Not eﬀective Minimally
eﬀective
Moderately
eﬀective
Very eﬀective Not exposed Missing
Lecture 2 71 91 0 0
Problem-based
learning (PBL)
0 31 31 12 0
Patient contact 0 126 19 1
Actor-based
simulation
0 014 23 1
Mannequin
simulation (including
today’s simulation)
0 1819 0 1
Other (textbook) 0 010 0 28
Most eﬀective method
Lectures PBL Patient contact Actor simulation Mannequin
simulation
Other
2 370 18 0
Prior exposure to
high-ﬁdelity
simulation
Acls only Acls and prior
simulation lab Other only No Missing
6 8211 1
Superiority of
simulation teaching
Strongly disagree Disagree Agree Strongly agree Unable to assess Missing
0 01 1 ∗ 13 3 2
∗One respondent agreed on the superiority of high-ﬁdelity mannequin-based teaching for malaria, with the caveat that direct participating rather than
observation was necessary for teaching aﬀectiveness.
Table 3: Postscenario test results.
N = 29 Correct Incorrect Missing Score (% correct)
Objective 1: recognizing high-risk groups 27 1 1 93
Objective 2: diagnosis
Diagnostic methods 20 7 2 69
Criteria for presumptive diagnosis 24 4 1 83
Objective 3: therapy
Criteria for presumptive therapy 27 2 0 93
First-line drug in USA 27 2 0 93
Complications of therapy 29 0 0 100
Objective 4: complications of severe malaria 16 12 1 55
Objective 5: resources for malaria 27 2 0 93
Totals 197 30 5 85
(95% CI 36, 97), and higher than problem-based learning by
6% (95% CI 0, 18) and lecture by 3% (95% CI 0, 10). 67%
of participants and 62% of observers rated simulation “very
eﬀective” (P = .78). Postsimulation knowledge scores were
equal in participants and observers (87% in both). There
were also no diﬀerences in eﬀectiveness ratings or test scores
among the three trainee groups (Tables 2 and 3).
6. Discussion
Our ﬁndings indicate a high learner satisfaction rate with
high-ﬁdelity simulation as a teaching tool for severe malaria.
The majority of the participants in our study rated the
simulation to be as eﬀective or superior to other teaching
methods. Additionally, our results suggest that not onlyJournal of Tropical Medicine 5
is simulation an eﬀective method of teaching in this case
b u tt h a ti tw a sa ne q u a l l ye ﬀective learning tool for both
observers and participants. These ﬁndings are important as
they indicate that we can eﬀectively utilize this expensive
technology to educate all learners involved in the process,
even if they are “just watching.” This allows us to increase
the number of participants or observers in one simulation
setting knowing they are being eﬀectively educated, thus
maximizing our educational investment.
Clinical simulations, including high-ﬁdelity simulations,
are increasingly used as an assessment tool in medical
education to test knowledge and competence [22]. High-
ﬁdelity simulation has often been used in teaching the
management of acute situations, particularly in emergency
medicine, critical care, and anesthesia. One literature review
of the use of high-ﬁdelity simulation in emergency medicine
found 11 papers directly relevant to the teaching of
emergency medicine [23]. Simulation applications included
airway management, trauma management (ATLS), team
performance training, presentation of ethical dilemmas,
management of disaster/crisis scenarios, and management
of medical errors. A survey of centers using simulation
in anesthesia training investigated the speciﬁc reasons for
the use of simulation [24]: rare events (75%) and crisis
management (80%) constituted the top two reasons for use
at the postgraduate level. Another study, also out of the
anesthesia literature, found that simulation-based training is
superior to problem-based learning in acute care scenarios
[25].
It is likely that physicians in training in industrialized
countries will encounter malaria during their training or
later in their career, whether at home or abroad. Global
health is an area of signiﬁcant student and faculty interest
and activity. The February 2008 issue of Academic Medicine
is entirely devoted to the development of global health
programs at academic medical centers. According to the
results of an AAMC survey, 26% of medical students
graduatingin2007hadhadaglobalhealthexperienceduring
medical school, and 43% felt their global health training
to be inadequate [26]. International rotations are now
an important component of many post-graduate training
programs in multiple specialties [27–29] and have an impact
on recruitment [30, 31]. It is therefore absolutely relevant to
teach malaria in academic centers in non-endemic countries.
Each year, patients in industrialized countries with
advanced medical care die preventable deaths from malaria,
attributable to physicians’ lack of familiarity with malaria
and its treatment [3, 5–7]. It is therefore critical to teach
the management of severe malaria eﬀectively. How can
medical educators better prepare trainees to recognize and
manage malaria? High-ﬁdelity simulation is a teaching tool
well suited to the acuity and time-dependent management
of severe malaria. This application has not been described
in the medical literature. The rarity of malaria in non-
endemic countries also supports the use of simulation, since
bedside teaching is not usually feasible. In this manner, high-
ﬁdelity simulation for malaria is similar to its application in
bioterrorism preparedness, another rare and life-threatening
situation [32, 33]. One can easily imagine the use of
simulation in teaching the management of other infectious
diseases and intoxications that may be rare but provide little
margin for error in diagnosis and treatment.
7. Limitations
This paper does not address the long-term eﬀectiveness of
the teaching intervention, that is, its impact on the retention
of knowledge and skills that have real-world applicability
in the treatment of severe malaria: The evaluation was
given immediately after the debrieﬁng that reemphasized
the learning objectives and critical actions. The subgroup of
practicing clinicians (8 emergency medicine residents) most
likely to use and beneﬁt from new knowledge in malaria
was small and perhaps too small a sample size to reach
conclusions applicable to this group.
One general limitation to simulation in medical edu-
cation is the lack of evidence of its impact on patient
outcomes.Ingeneral,thereisgoodevidencethatsimulation-
based training improves performance in simulated scenarios
themselves [34]. In the particular case of manual skills and
procedures, simulation-based training does actually improve
real-world operational performance [34].
8. Conclusions
High-ﬁdelity simulation constitutes a novel tool for teaching
severe malaria that can meet speciﬁc learning objectives by
demonstrating the need for time-dependent critical actions.
In non-endemic countries it may be rare to witness a case
of this disease, but, given its life-threatening nature, it is
imperative that our learners are aware of this disease, know
how to treat it, and have experience with its presentation,
whether real or simulated, so they can manage it quickly and
eﬀectively as health care providers.
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